Cutler Group’s AngioDynamics ANGO Stock Holding History

Cutler Group’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,500	Closed	-$2K	–	6296
2017 Q1	$2K	Buy	+4,500	New	+$75.2K	﹤0.01%	5358

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Cutler Group's ANGO Position: Q2 2021 in Review

Cutler Group sold out of AngioDynamics (ANGO) in Q2 2021, closing a stake of 422 shares — an estimated $9K sold.

Cutler Group first reported a position in ANGO in Q4 2015 and held it in 8 quarters. The position peaked at $141K in Q3 2017. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2021.

Cutler Group reported no remaining AngioDynamics position as of Q2 2021 after selling out during the quarter.
Cutler Group sold 422 AngioDynamics shares in Q2 2021, an estimated $9K.
Cutler Group first reported a position in AngioDynamics in Q4 2015 and held it in 8 quarters.
Cutler Group's AngioDynamics position peaked at $141K in Q3 2017.
161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.